UKKA Clinical Practice Guideline: #Anticoagulation for atrial fibrillation in adults with advanced kidney disease #Afib #CKD @livuninews.bsky.social @livhp.bsky.social
www.ukkidney.org/sites/defaul...

📣Review Sharing: Volume 87,Issue 3

🧾Stuck Between a Rock and a Hard Place: Anticoagulation in End-Stage Kidney Disease Patients With Atrial Fibrillation

👩‍🔬Samuel Sherng Young Wang,Muhammad Masoom Javaid

📌Full Text: imrpress.com/journal/BJHM...
#anticoagulation #AF #ESKD #MedEd #MedSky #AcademicSky

Smart Technology–Assisted Patient-Centered Management in Venous Thromboembolism: Pilot Study on Anticoagulation Adherence Background: Achieving optimal adherence to anticoagulation therapy is a major challenge in the management of venous thromboembolism (VTE). Mobile health (mHealth) technologies may offer a scalable approach to supporting medication adherence and self-management. Objective: This pilot study aimed to assess the #feasibility and preliminary impact of a smart technology–assisted, patient-centered care mHealth app for managing VTE (mVTEA) on short-term anticoagulation adherence among patients with VTE or at moderate-to-high risk of VTE. Methods: Baseline medication adherence and beliefs were assessed using the Chinese versions of the 8-item Morisky Medication Adherence Scale and the Beliefs about Medicines Questionnaire–Specific to characterize baseline status only. The primary outcome was perfect adherence at 1 month, assessed through structured telephone interviews, outpatient visits, and the mVTEA physician-patient communication module. During follow-up, researchers verified current medication regimens, recorded missed doses, assessed therapy continuation, and whenever possible, confirmed adherence through pharmacy refill records or remaining medication packaging. Secondary outcomes included the mVTEA check-in rate and clinical safety events (VTE recurrence, major bleeding per International Society on Thrombosis and Haemostasis criteria, VTE-related hospitalizations, VTE-related rehospitalizations, all-cause mortality). Results: In total, 45 participants completed the study (mean age 60.80, SD 15.20 years; n=16, 36% female). Baseline 8-item Morisky Medication Adherence Scale scores indicated suboptimal adherence (mean 6.24, SD 1.80), with 29% (13/45) classified as good adherence and 71% (32/45) as moderate or poor adherence. The primary contributors to nonadherence were forgetting to take medication. Baseline Beliefs about Medicines Questionnaire–Specific scores showed stronger beliefs in medication necessity than concerns (17.58, SD 2.52 vs 14.56, SD 3.34;

JMIR Formative Res: Smart Technology–Assisted Patient-Centered Management in Venous Thromboembolism: Pilot Study on Anticoagulation Adherence #HealthTech #VenousThromboembolism #Anticoagulation #mHealth #MedicationAdherence

🔥🐔 Hot takes on #anticoagulation straight from the Hot Chicken Capital courtesy of our close HMS partner, Dr. Scott Kaatz of @henryfordhealth.bsky.social 🩸

His sessions are always insightful, entertaining, and this one was well-seasoned with the latest research!

#SHMConverge26

💊 Anticoagulation Awareness | Glendale Academy

Learn safe use, Monitoring, and risks of anticoagulants. Improve medication safety and patient outcomes through evidence-based practice.

📲 zurl.co/nx8l5

#Anticoagulation #MedicationSafety #CPD #HealthcareTraining

🩸 Thrombosis & Anticoagulation

When NOT to use DOACs? What’s next—Factor XI inhibitors?

Join experts Stephanie Carlin, Jeffrey Weitz & Jack Hirsh for key insights on managing thrombosis & bleeding risk.

📅 May 9 | 11:10–12:35
📍 Kraków & online
👉 www.mircim.one
#Thrombosis #Anticoagulation #MIRCIM

The Lowdown on Medications and Antiphospholipid Syndrome (Warfarin, Enoxaparin, DOACs, NSAIDs & More) Learn more about medications and Antiphospholipid Syndrome - from vitamin K antagonists (warfarin), enoxaparin, DOACs, NSAIDS and more.

"..future #AntiphospholipidSyndrome #treatments might shift to an immunological one, instead of merely targeting #anticoagulation. Unfortunately, despite the implication of [protease-activated receptors] in APS, there are no ongoing trials for APS patients.": buff.ly/PxlQVVv

#MondayBlogs #MedSky

Prescribing dilemma: balancing risk and benefit when prescribing anticoagulation in an older patient with falls risk This case example explores how uncertainty can arise when interpreting clinical guidelines to prescribe anticoagulation for older patients who are at risk of falls.  A list of the skills required to…

This real-world prescribing dilemma, written by #AmiraShaikh, examines the decision-making process when considering anticoagulation in older patients

#prescribingdilemma #anticoagulation #fallsrisk

📣 #Anticoagulation Therapeutic Ranges and Outcomes in pts with a Mechanical Heart Valve Treated with VKA

📌 Visser et al. found ⬇️ therapeutic range does not apparently increase TE risk in most pts, but may be linked to ⬆️ risk in higher risk pts

👉 www.thieme-connect.de/products/ejo...

#Cardiosky

Case-based learning: women's health and anticoagulation Introduction Anticoagulants are commonly prescribed, high-risk medications. The direct oral anticoagulants (DOACs) are frequently used to treat venous thromboembolism (VTE) and for stroke prevention…

Our latest case-based learning article looks at considerations for anticoagulation in the presence of heavy menstrual bleeding

#ukpharmacy #womenshealth #anticoagulation

This case shows argatroban as a lifesaving bridge and a cautious transition to apixaban, despite recent subdural hematoma. Would you anticoagulate, or hold, in this scenario?

Read more: www.cureus.com/articles/437...

#Cureus #Hematology #Neurology #MedEd #Anticoagulation #MedSky

Case-based learning: women's health and anticoagulation Introduction Anticoagulants are commonly prescribed, high-risk medications. The direct oral anticoagulants (DOACs) are frequently used to treat venous thromboembolism (VTE) and for stroke prevention…

In this case-based learning article, #RosalindByrne highlights how considerations for anticoagulation in the presence of heavy menstrual bleeding can change over a woman’s life course

#ukpharmacy #womenshealth #anticoagulation

Efficacy and Safety of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Left Ventricular Thrombus: A Systematic Review and Meta-Analysis Left ventricular thrombus (LVT) is a serious complication associated with myocardial infarction and cardiomyopathy. While vitamin K antagonists (VKAs) have been the standard treatment, direct oral ant...

Left Ventricular Thrombus (LVT) is a dangerous complication of heart attacks. Guidelines traditionally favor Warfarin. But are DOACs just as good at dissolving the clot?

doi.org/10.7759/cureus.84941

#WeiPublications #CardioSky #Hematology #MedSky #Cardiology #LVT #Anticoagulation #FOAMed

Anticoagulation versus no anticoagulation after intracranial hemorrhage in patients with atrial fibrillation: an updated systematic review and meta-analysis - BMC Cardiovascular Disorders Background Patients with atrial fibrillation (AF) and prior intracranial hemorrhage (ICH) present a therapeutic dilemma, where stroke prevention benefits of anticoagulation must be weighed against rec...

#Anticoagulation after intracranial hemorrhage in #AF patients: Updated #MetaAnalysis of 5 RCTs (n=733).
🧠 80% ↓ ischemic stroke (NNT=9); 64% ↓ major ischemic events (NNT=11).
⚠️ ↑ ICH risk x3.7 (NNH=24); major bleeding x2.4 (NNH=23). No mortality difference.
#ICH link.springer.com/article/10.1...

Embedding Sustainability Into Anticoagulation Care Researchers issued a multidisciplinary call to embed sustainability into anticoagulation care.

In a review published in @thelancethaem.bsky.social, Bingwen Eugene Fan, MBBS, of Tan Tock Seng Hospital, and colleagues issued a multidisciplinary call to embed #sustainability into #anticoagulation care.

https://bit.ly/4jeQo1y

NEW: Effect of Clinical Decision Support Alerts on #Anticoagulation Management in #AtrialFibrillation

www.thieme-connect.com/products/ejo...

#MedSky #CardioSky #CDS #ClinicalDecisionSupport #DigitalHealth

Excited to share this article highlighting the important role of Antithrombosis Stewardship to improve Safe Transitions of Care in pts with VTE.
#Stewardship #Anticoagulation #AntithromboticStewardship #TransitionsofCare
@jthjournal.bsky.social @isth.org

www.sciencedirect.com:5037/science/arti...

Continuar anticoagulante oral por 90d o más en pacientes con un tromboembolismo venoso se asocia con una menor tasa de recurrencia del tromboembolismo, mayor tasa de sangrado mayor y un beneficio clínico neto, que persiste al menos por 3a #VTE #Anticoagulation www.bmj.com/content/391/...

The November issue is now online!

👉 Read our latest articles!

🔗 onlinelibrary.wiley.com/toc/13652796/2025/298/5

#kidneys #CKD #neuroendocrinology #addiction #antibiotics #arteritis #PMR #retroperitoneal #fibrosis #anticoagulation #gastrointestinal #bleeding #atrialfibrillation #HDL #coronary

#Anticoagulation in #Afib and #ESRD & #AdvCKD got you down? 😞

Is uncoupling thrombosis & hemostasis is the answer! ✅

#FactorIX inhibitors may be the answer to the longstanding conundrum?

#AtrialFibrillation #FactorXIInhibitors

https://ow.ly/rxib50XhaCi

Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients With Mechanical Valves | Neurology Background and ObjectivesIn patients with mechanical heart valves (MHVs), anticoagulation (AC) interruption after intracranial hemorrhage (ICH) poses a clinical dilemma because of competing risks of ischemic complications and hemorrhagic recurrence. To ...

How long do you wait to restart #anticoagulation in a patient with #ICH and #MechanicalHeartValve? #neurocritcare

Are you the person everyone calls when anticoagulation gets complicated?
Then you’ll fit right in at the Thrombosis Canada Annual Conference!

Join colleagues from across the country to connect, learn, and debate complex #VTE and #Anticoagulation cases during our Morning Report.

thrombosiscanada.ca

🩸 NATA webinar today!
Anticoagulant & Antifibrinolytic Stewardship
🎙️ Dr Pieter Wessels — Anticoagulation Stewardship: what, why & how
🎙️ Dr Michelle Sholzberg — Tranexamic acid in women’s health

🔗 nataonline.com/monthly-live-webinars/

#PBM #Anticoagulation #TranexamicAcid #WTD25 #ISTH #thrombosis

🛜Webinar tomorrow 16 Oct

Anticoagulant & Antifibrinolytic Stewardship
🎙️ Dr Pieter Wessels — Anticoagulation Stewardship: what, why & how
🎙️ Dr Michelle Sholzberg — Tranexamic acid in women’s health

🔗 nataonline.com/monthly-live-webinars/
#PBM #Anticoagulation #TranexamicAcid #HCP #WTD25

- Prophylactic or therapeutic #anticoagulation Tx should be considered to mitigate the high risk of thromboembolic events
- Post-recovery monitoring for long-term 🫀 complications is important, especially for patients with a hx of #diabetes.

Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source | Neurology Background and ObjectivesThe term “embolic stroke of undetermined source” (ESUS) encompasses a substantial but heterogeneous population of patients with ischemic stroke, underscoring the importance of identifying personalized treatment strategies. In ...

8/ #ESUS = suspected cardioembolic stroke but w/o afib. #Anticoagulation in this patient population has not definitively demonstrated to be superior to #antiplatelet



A recent meta analysis of the available trials showed no superiority:

Researchers are working to identify the specific types of patients who might benefit from #anticoagulation to determine the best timing & duration of treatment.
Potential for Broader Impact: If proven effective,

Pour les AVK spécifiquement :

Envisager l'arrêt si prescrits pour une thrombose veineuse profonde ou une embolie pulmonaire non compliquée survenue il y a plus de 6 mois chez les personnes sans cancer.

88,6% des experts sont d'accord.

#Déprescription #Anticoagulation
5/15

Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry Click on the article title to read more.

New data from the #RIETE registry (111k+ pts): Baseline hemoglobin strongly predicts outcomes in acute #VTE.
Low Hb= ↑bleeding & mortality
High Hb= ↓bleeding risk
Hb may be an overlooked but independent prognostic marker. Time to tailor #anticoagulation by Hb? onlinelibrary.wiley.com/doi/10.1002/...

This study on #anticoagulation in patients nearing end of life reveals a decline in vitamin K antagonist control, marked by reduced time in therapeutic range  and increased time above therapeutic range and variance growth rate, suggesting higher bleeding risk.  #VKA

👉https://bit.ly/453BpRq